CLARIANE SE (CLARI.PA) Stock Fundamental Analysis
EPA:CLARI - Euronext Paris - Matif - FR0010386334 - Common Stock - Currency: EUR
We assign a fundamental rating of 3 out of 10 to CLARI. CLARI was compared to 25 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of CLARI have multiple concerns. CLARI has a decent growth rate and is not valued too expensively. CLARI also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
CLARI had negative earnings in the past year.
CLARI had a positive operating cash flow in the past year.
CLARI had positive earnings in 4 of the past 5 years.
In the past 5 years CLARI always reported a positive cash flow from operatings.
1.2 Ratios
CLARI has a worse Return On Assets (-1.09%) than 83.33% of its industry peers.
With a Return On Equity value of -4.55%, CLARI is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
With a Return On Invested Capital value of 2.33%, CLARI is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
Measured over the past 3 years, the Average Return On Invested Capital for CLARI is below the industry average of 5.68%.
The last Return On Invested Capital (2.33%) for CLARI is above the 3 year average (2.31%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.09% | ||
| ROE | -4.55% | ||
| ROIC | 2.33% |
ROA(3y)0.03%
ROA(5y)0.29%
ROE(3y)0.1%
ROE(5y)1.21%
ROIC(3y)2.31%
ROIC(5y)2.44%
1.3 Margins
CLARI has a Operating Margin (6.56%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of CLARI has declined.
CLARI's Gross Margin of 91.86% is amongst the best of the industry. CLARI outperforms 95.83% of its industry peers.
CLARI's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.56% | ||
| PM (TTM) | N/A | ||
| GM | 91.86% |
OM growth 3Y-4.68%
OM growth 5Y-6.58%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.07%
GM growth 5Y-0.03%
2. Health
2.1 Basic Checks
CLARI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, CLARI has more shares outstanding
The number of shares outstanding for CLARI has been increased compared to 5 years ago.
CLARI has a better debt/assets ratio than last year.
2.2 Solvency
CLARI has an Altman-Z score of 0.58. This is a bad value and indicates that CLARI is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CLARI (0.58) is worse than 70.83% of its industry peers.
CLARI has a debt to FCF ratio of 14.61. This is a negative value and a sign of low solvency as CLARI would need 14.61 years to pay back of all of its debts.
The Debt to FCF ratio of CLARI (14.61) is worse than 79.17% of its industry peers.
CLARI has a Debt/Equity ratio of 1.96. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.96, CLARI is doing worse than 62.50% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.96 | ||
| Debt/FCF | 14.61 | ||
| Altman-Z | 0.58 |
ROIC/WACC0.97
WACC2.4%
2.3 Liquidity
CLARI has a Current Ratio of 0.58. This is a bad value and indicates that CLARI is not financially healthy enough and could expect problems in meeting its short term obligations.
CLARI has a worse Current ratio (0.58) than 83.33% of its industry peers.
CLARI has a Quick Ratio of 0.58. This is a bad value and indicates that CLARI is not financially healthy enough and could expect problems in meeting its short term obligations.
CLARI has a Quick ratio of 0.57. This is in the lower half of the industry: CLARI underperforms 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.58 | ||
| Quick Ratio | 0.57 |
3. Growth
3.1 Past
CLARI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1311.11%.
Looking at the last year, CLARI shows a quite strong growth in Revenue. The Revenue has grown by 9.38% in the last year.
Measured over the past years, CLARI shows a quite strong growth in Revenue. The Revenue has been growing by 8.42% on average per year.
EPS 1Y (TTM)-1311.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4800%
Revenue 1Y (TTM)9.38%
Revenue growth 3Y9.81%
Revenue growth 5Y8.42%
Sales Q2Q%7.11%
3.2 Future
The Earnings Per Share is expected to grow by 61.03% on average over the next years. This is a very strong growth
CLARI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.28% yearly.
EPS Next Y-431.43%
EPS Next 2Y5.61%
EPS Next 3Y61.03%
EPS Next 5YN/A
Revenue Next Year5.9%
Revenue Next 2Y5.13%
Revenue Next 3Y5%
Revenue Next 5Y5.28%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for CLARI. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 29.05, CLARI can be considered very expensive at the moment.
CLARI's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. CLARI is more expensive than 66.67% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 92.74, CLARI is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 29.05 |
4.2 Price Multiples
70.83% of the companies in the same industry are more expensive than CLARI, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, CLARI is valued cheaply inside the industry as 95.83% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 1.49 | ||
| EV/EBITDA | 8.18 |
4.3 Compensation for Growth
CLARI's earnings are expected to grow with 61.03% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.61%
EPS Next 3Y61.03%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 10.64%, CLARI is a good candidate for dividend investing.
CLARI's Dividend Yield is rather good when compared to the industry average which is at 2.89. CLARI pays more dividend than 100.00% of the companies in the same industry.
CLARI's Dividend Yield is rather good when compared to the S&P500 average which is at 2.28.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 10.64% |
5.2 History
The dividend of CLARI is nicely growing with an annual growth rate of 6.29%!
Dividend Growth(5Y)6.29%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
The earnings of CLARI are negative and hence is the payout ratio. CLARI will probably not be able to sustain this dividend level.
CLARI's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-43.4%
EPS Next 2Y5.61%
EPS Next 3Y61.03%
CLARIANE SE
EPA:CLARI (2/5/2025, 1:30:09 PM)
2.394
+0.03 (+1.35%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners40.48%
Inst Owner ChangeN/A
Ins Owners5.48%
Ins Owner ChangeN/A
Market Cap852.22M
Analysts43.64
Price Target1.83 (-23.56%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 10.64% |
Yearly Dividend0.47
Dividend Growth(5Y)6.29%
DP-43.4%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-22%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)7.35%
EPS NY rev (3m)7.35%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.28%
Revenue NY rev (3m)0.28%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 29.05 | ||
| P/S | 0.16 | ||
| P/FCF | 1.49 | ||
| P/OCF | 0.91 | ||
| P/B | 0.24 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.18 |
EPS(TTM)-1.09
EYN/A
EPS(NY)0.08
Fwd EY3.44%
FCF(TTM)1.6
FCFY66.9%
OCF(TTM)2.62
OCFY109.6%
SpS14.52
BVpS9.8
TBVpS-5.93
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.09% | ||
| ROE | -4.55% | ||
| ROCE | 2.96% | ||
| ROIC | 2.33% | ||
| ROICexc | 2.44% | ||
| ROICexgc | 4.99% | ||
| OM | 6.56% | ||
| PM (TTM) | N/A | ||
| GM | 91.86% | ||
| FCFM | 11.03% |
ROA(3y)0.03%
ROA(5y)0.29%
ROE(3y)0.1%
ROE(5y)1.21%
ROIC(3y)2.31%
ROIC(5y)2.44%
ROICexc(3y)2.5%
ROICexc(5y)2.63%
ROICexgc(3y)5%
ROICexgc(5y)5.37%
ROCE(3y)2.93%
ROCE(5y)3.09%
ROICexcg growth 3Y-4.57%
ROICexcg growth 5Y-22.08%
ROICexc growth 3Y-1.72%
ROICexc growth 5Y-11.85%
OM growth 3Y-4.68%
OM growth 5Y-6.58%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.07%
GM growth 5Y-0.03%
F-Score5
Asset Turnover0.35
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.96 | ||
| Debt/FCF | 14.61 | ||
| Debt/EBITDA | 6.48 | ||
| Cap/Depr | 50.71% | ||
| Cap/Sales | 7.04% | ||
| Interest Coverage | 1.31 | ||
| Cash Conversion | 88.38% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.58 | ||
| Quick Ratio | 0.57 | ||
| Altman-Z | 0.58 |
F-Score5
WACC2.4%
ROIC/WACC0.97
Cap/Depr(3y)83.89%
Cap/Depr(5y)84.33%
Cap/Sales(3y)12.16%
Cap/Sales(5y)11.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1311.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4800%
EPS Next Y-431.43%
EPS Next 2Y5.61%
EPS Next 3Y61.03%
EPS Next 5YN/A
Revenue 1Y (TTM)9.38%
Revenue growth 3Y9.81%
Revenue growth 5Y8.42%
Sales Q2Q%7.11%
Revenue Next Year5.9%
Revenue Next 2Y5.13%
Revenue Next 3Y5%
Revenue Next 5Y5.28%
EBIT growth 1Y9.47%
EBIT growth 3Y4.67%
EBIT growth 5Y1.29%
EBIT Next Year235.42%
EBIT Next 3Y57.82%
EBIT Next 5Y43.91%
FCF growth 1Y63.88%
FCF growth 3Y5.21%
FCF growth 5Y23.21%
OCF growth 1Y3.84%
OCF growth 3Y0.39%
OCF growth 5Y16.34%